⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XRTX News
XORTX Therapeutics Inc. Common Stock
IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
BHVN
NVO
LLY
LXRX
XRTX
REGN
FMS
MDT
AMPH
DRCT
BMRC
MAZE
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
globenewswire.com
XRTX
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
globenewswire.com
XRTX
XORTX Announces Closing of US$5 Million Public Offering
globenewswire.com
XRTX
E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering
globenewswire.com
XRTX
XORTX Announces US$5 Million Public Offering
globenewswire.com
XRTX
XORTX Meets Nasdaq Continued Listing Requirements
globenewswire.com
XRTX
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
globenewswire.com
XRTX
XORTX Confirms Effective Date of Share Consolidation
globenewswire.com
XRTX
XORTX Announces Results of Annual and Special Meeting of Shareholders
globenewswire.com
XRTX